欧盟法规
ECHA物质C&L通报上下游产品
CAS号1007-16-5 3-溴-4-氟苯甲酸 | CAS号74-88-4 碘甲烷 | CAS号161957-56-8 3-溴-2-氟苯甲酸 | CAS号149-73-5 原甲酸三甲酯 | CAS号67-56-1 甲醇 | CAS号77771-03-0 3-溴-4-氟苄胺盐酸盐 | CAS号1195765-45-7 达拉菲尼 | CAS号1195768-18-3 2-氟-3-胺基苯甲醚合成工艺路线路线简述
- 合成目标产物 3-Bromo-2-Fluorobenzoic Acid Methyl Ester 主要起始原料 3-Bromo-4-Fluorobenzoic Acid And Iodomethane
- (文献来源)合成步骤主要原料 3-Bromo-4-Fluorobenzoic Acid 和 Iodomethane
3-溴-4-氟苯甲酸,碘甲烷置于potassium Carbonate体系中,用 甲基叔丁基醚,N,N-二甲基甲酰胺 用作溶剂,化学反应 16.0H,以89.5%的收率获得3-溴-2-氟苯甲酸甲酯
参考文献:Wo2007/61930
标题:Wo2007/61930
海关参考信息
- 2906210000-苄醇
2912110000-甲醛
2912210000-苯甲醛
2915110000-甲酸 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2018065917-A1
优先权日:2016-09-02
标 题 :Immune checkpoint inhibitors, compositions and methods thereof
发明人:WEBBER STEPHEN E; ALMASSY ROBERT J
权利人:POLARIS PHARMACEUTICALS INC
摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula (I), or a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof. n n n n n n n n n n For Formula (I) compounds R 1 , R 2 , X 1 , Y 1 and n are as defined in the specification. The inventive Formula (I) compounds are inhibitors of the PD-1/PD-L1 protein/protein binding or functional interaction and find utility in any number of therapeutic applications, including but not limited to treatment of proliferative disorders such as cancer and infectious diseases.
专利号:CN-116139138-A
优先权日:2016-11-11
标题:Heterocyclic regulators of lipid synthesis
专利号:CN-110177551-B
优先权日:2016-11-11
标 题:Heterocyclic modulators of lipid synthesis